Barriers to use of free antiretroviral therapy in injection drug users

JAMA

Volumn 280, Issue 6, 1998, Pages 547-549

  Strathdee, Steffanie A ^a   Palepu, Anita ^a   Cornelisse, Peter G A ^a   Yip, Benita ^a   O'Shaughnessy, Michael V ^a   Montaner, Julio S G ^a   Schlechter, Martin T ^a   Hogg, Robert S ^a  

^a ST PAUL S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; VIRUS RNA; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CANADA; CONTROLLED STUDY; DRUG UTILIZATION; FEMALE; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL;

EID: 0032511413     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.280.6.547     Document Type: Article

References (21)

1. Patrick DM, Strathdee SA, Archibald CP, et al. Determinants of HIV seroconversion in injection drug users during a period of rising prevalence in Vancouver. Int J STD AIDS. 1997;8:437-445.
2. StrathdeeSA,PatrickDM,CurrieSL,etal.Needle exchange is not enough. AIDS. 1997;11:F59-FG5.
3. Hogg RS, Heath KV, Yip B, et al. Improved survival among HI V-infected individuals. JAMA. 1998; 279:450-454.
4. Hammer SM, Squires KE, Hughes MD, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Meet. 1997;337:725-733.
5. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med. 1998;338:853-860.
6. Vernazza PL, Gilliam BL, Flepp M, et al. Effect of antiviral treatment on the shedding of HIV-1 in semen. AIDS. 1997;11:1249-1254.
7. Cardo DM, Culver DH, Ciesielski CA, et al, Centers for Disease Control and Prevention Needlestick Surveillance Group. A case-control study of HIV seroconversion in health care workers after percutaneous exposure. N Engl J Med. 1997;337:1485-1490.
8. Bangsberg D, Tulsky JP, Hecht RM, Moss AR. Protease inhibitors in the homeless. JAMA. 1997; 278:63-65.
9. Carpenter CCJ, Fischl MA, Hammer SM, et al. Antiretroviral therapy for HI V infection in 1997: updated recommendations of the International AIDS Society-USA Panel JAMA. 1997;277;1962-1969.
10. Montaner JSG, O'Shaughnessy MV. Therapeutic Guidelines for the Treatment of HIV/AIDS and Related Conditions. Vancouver: British Columbia Centre for Excellence in HIV/AIDS; 199G.
11. Markson LE, Cosler LE, Turner BJ. Implications of generalists' slow adoption of zidovudine in clinical practice. Arch Intern Med. 1994;154:1497-1504.
12. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CI, Dodge WT, Wagner EH. Physicians'experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996;334:701-706.
13. Heath KV, Hogg RS, Singer J, Schechter MT, O'Shaughnessy MV, Montaner JS. Adherence to clinical guidelines for the therapeutic management of HIV disease. Clin Invest Med. 1997;20:381-387.
14. O'Connor PG, Molde S, Henry S, Schockcor WT, Schottenfeld RS. Human immunodeficiency virus infection in intravenous drug users: a model for primary care. Am J Med. 1992;93:382-386.
15. Celentano DD, Vlahov D, Cohn S, Shadle VM, Olugbenga 0, Moore RD. Self-reported antiretroviral therapy in injection drug users. JAMA. 1998; 280:544-546.
16. Moore RD, Stanton D.Gopalan R, Chaisson RE. Racial differences in the use of drug therapy for HIV disease in an urban community. N Engl J Med. 1994;330:763-768.
17. Stein MD, Piette J, Mor V, et al. Differences in access to zidovudine (AZT) among symptomatic HIV-infected pel-sons. J Gen Intern Med. 1991;6:35-40.
18. Mor V, Fleishman JA, Dresser M, Piette J. Variation in health service use among HIV-infected patients. Med Care. 1992;30:17-29.
19. Hellinger FJ. The use of health services by women with HIV infection. Health Serv Res. 1993;8: 543-561.
20. Palepu A, Strathdee SA, Anis AH, et al. Health services utilization in a cohort of injection drug users. Can J Infect Dis. 1997;8:27A.
21. Graham NM, Jacobson LP, Kuo V, Chmiel JS, Morgenstern H, Zucconi SL. Access to therapy in the Multicenter AIDS Cohort Study, 1989-1992. J Clin Epidemiol. 1994;47:1003-1012.